Margaret Bolce Brivanlou

Margaret "Peg" Bolce Brivanlou is a licensed patent attorney and experienced IP counselor who represents biotechnology and pharmaceutical companies and institutions in the spectrum of patent matters, including patent prosecution and portfolio development and management. Peg also advises investment funds and other clients on the intellectual property aspects of transactions, including licensing as well as transfer of technology and other assets.

Peg applies her skills and knowledge, including a doctorate in molecular biology, to represent clients in the biologics and small molecule therapeutics industries. She advises on immunotherapeutics, cell-based assays and therapies, genomics, bioinformatics, vaccines, and small molecule pharmaceuticals. Peg has experience developing patent portfolios, particularly for biologics, antibody therapeutics, and diagnostics. She also handles patent invalidity, freedom-to-operate analyses, and pre-litigation investigations, including for pre-Hatch-Waxman litigation involving generic drug claims.

Peg’s work on the intellectual property facets of transactions includes handling multi-million-dollar asset purchases and financings, technology transfer, and out-licensing. She conducts due diligence and negotiates disclosure documents, as well as licensing and purchase agreements, in public and private financings.

Admissions

New York